Barclays
RGEN icon

Barclays’s Repligen RGEN Stock Holding History

Barclays’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$2.67M – 5602
2025
Q3 		$2.67M Sell
20,000
-60,000
-75% -$7.29M ﹤0.01% 2658
2025
Q2 		$9.95M Buy
80,000
+10,000
+14% +$1.27M ﹤0.01% 1589
2025
Q1 		$8.91M Buy
70,000
+50,000
+250% +$7.7M ﹤0.01% 1488
2024
Q4 		$2.88M Buy
+20,000
New +$2.87M ﹤0.01% 2616
2017
Q3 		– Sell
-40,000
Closed -$1.66M – 7008
2017
Q2 		$1.66M Hold
40,000
– – ﹤0.01% 2419
2017
Q1 		$1.41M Buy
+40,000
New +$1.27M ﹤0.01% 2415

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Barclays's RGEN Position: Q2 2026 in Review

Barclays reduced its Repligen (RGEN) stake by 20% in Q2 2026, selling an estimated $4.7M and leaving 155,745 shares worth $21.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Barclays first reported a position in RGEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.3M in Q3 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Barclays held 155,745 shares of Repligen worth $21.2M as of Q2 2026.
  • Barclays sold 38,271 Repligen shares in Q2 2026, an estimated $4.7M.
  • Repligen made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1100 holding.
  • Barclays first reported a position in Repligen in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Repligen position peaked at $34.3M in Q3 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.